Daohui Ge

Daohui Ge


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in BMC Genomics
Verified
Journal Article
Open access
PDF file
XMXianghan Meng
Xianghan Meng
Junliang ShangJunliang Shang
Junliang Shang
DGDaohui Ge
Daohui Ge
YYYi Yang
Yi Yang
TZTongdui Zhang
Tongdui Zhang
JLJin-Xing Liu
Jin-Xing Liu
Background: Piwi-interacting RNAs (piRNAs) have been proven to be closely associated with human diseases. The identification of the potential associations between piRNA and disease is of great significance for complex diseases. Traditional “wet experiment” is time-consuming and high-priced, predicting the piRNA-disease associations by computational methods is of great significance. Methods: In this paper, a method based on the embedding transformation graph convolution network is proposed to predict the piRNA-disease associations, named ETGPDA. Specifically, a heterogeneous network is constructed based on the similarity information of piRNA and disease, as well as the known piRNA-disease associations, which is applied to extract low-dimensional embeddings of piRNA and disease based on graph convolutional network with an attention mechanism. Furthermore, the embedding transformation module is developed for the problem of embedding space inconsistency, which is lightweighter, stronger learning ability and higher accuracy. Finally, the piRNA-disease association score is calculated by the similarity of the piRNA and disease embedding. Results: Evaluated by fivefold cross-validation, the AUC of ETGPDA achieves 0.9603, which is better than the other five selected computational models. The case studies based on Head and neck squamous cell carcinoma and Alzheimer’s disease further prove the superior performance of ETGPDA. Conclusions: Hence, the ETGPDA is an effective method for predicting the hidden piRNA-disease associations.

19 November 2024 in International Journal of Neural Systems
Verified
Journal Article
Closed access
WHWenrong Hu
Wenrong Hu
JWJuan Wang
Juan Wang
FLFeng Li
Feng Li
DGDaohui Ge
Daohui Ge
YWYuxia Wang
Yuxia Wang
SYShasha Yuan
Shasha Yuan

9 September 2024 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
Junliang ShangJunliang Shang
Junliang Shang
LZLinqian Zhao
Linqian Zhao
XHXin He
Xin He
XMXianghan Meng
Xianghan Meng
LZLimin Zhang
Limin Zhang
JLJin-xing Liu
Jin-xing Liu
Circular RNAs (circRNAs) have emerged as a novel class of non-coding RNAs with regulatory roles in disease pathogenesis. Computational models aimed at predicting circRNA-disease associations offer valuable insights into disease mechanisms, thereby enabling the development of innovative diagnostic and therapeutic approaches while reducing the reliance on costly wet experiments. In this study, SGFCCDA is proposed for predicting potential circRNA-disease associations based on scale graph convolutional networks and feature convolution. Specifically, SGFCCDA integrates multiple measures of circRNA and disease similarity and combines known association information to construct a heterogeneous network. This network is then explored by scale graph convolutional networks to capture both topological and attribute information. Additionally, convolutional neural networks are employed to further learn the features and obtain higher-order feature representations containing richer information about nodes. The Hadamard product is utilized to effectively combine circRNA features with disease features, and a multilayer perceptron is applied to predict the association between each pair of circRNA and disease. Five- fold cross validation experiments conducted on the CircR2Disease dataset demonstrate the accurate prediction capabilities of SGFCCDA in identifying potential circRNA-disease associations. Furthermore, case studies provide further confirmation of SGFCCDA's ability to identify disease-associated circRNAs.

5 September 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
LQLongfei Qi
Longfei Qi
FLFeng Li
Feng Li
Junliang ShangJunliang Shang
Junliang Shang
DGDaohui Ge
Daohui Ge
SWShihan Wang
Shihan Wang
SYShasha Yuan
Shasha Yuan
Accurate early prediction of epileptic seizures is crucial for improving patients' quality of life. However, existing seizure prediction methods often rely on large-scale labeled datasets and face challenges in generalization and real-time performance. To address these issues, this study proposes an efficient seizure prediction framework that achieves high performance even with limited labeled data, significantly reducing dependence on extensive annotations. To better distinguish preictal states, contrastive learning is employed to enhance feature separation between interictal and preictal periods, leading to improved sensitivity in detecting early seizure patterns. First, a data augmentation strategy is designed, incorporating wavelet-based frequency mixing, temporal masking, and window-based masking to enhance model robustness and generalization. Second, a hierarchical contrastive loss function is introduced, integrating instance-level and temporal contrastive learning to improve the model's ability to capture preictal patterns. Finally, a lightweight SE-EEGNet is developed and optimized as a feature extractor, strengthening critical feature extraction and enabling real-time seizure prediction. On the CHB-MIT dataset, the proposed method achieves 94.51% accuracy, 95.05% sensitivity, a 0.024/h false positive rate (FPR), and a 20.12-minute prediction time using only 30% labeled data. On the Siena dataset, it achieves 93.14% accuracy, 92.77% sensitivity, and a 0.030/h FPR. Moreover, performance improves further as the amount of labeled data increases, validating the effectiveness and practical applicability of the proposed approach in seizure prediction.

3 January 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
XHXin He
Xin He
Junliang ShangJunliang Shang
Junliang Shang
DGDaohui Ge
Daohui Ge
FLFeng Li
Feng Li
JLJin-xing Liu
Jin-xing Liu
Numerous studies have demonstrated the regulatory role of circular RNA (circRNA) in various diseases, emphasizing the importance of identifying disease-related circRNAs. Although several computational models have been developed to predict circRNA-disease associations, the limited number of experimentally validated associations has resulted in the sparse association network. Therefore, there is a need for continuously improving circRNA-disease prediction models. In this study, we propose RPMVCDA, a computational model based on random perturbation and multi-view graph convolutional networks (GCNs), to predict circRNA-disease associations. Specifically, RPMVCDA first constructs multiple similarity networks of circRNAs and diseases, applying multi-view GCNs to obtain embedding representations. Second, to enable message passing between circRNA-disease samples, RPMVCDA constructs the feature similarity association network. Third, RPMVCDA introduces a random perturbation association network to further explore the potential associations, which is the highlight of the RPMVCDA. Finally, based on these three association networks, RPMVCDA utilizes the self-attention mechanism to generate high-quality features for circRNAs and diseases, which are used to calculate association scores. To evaluate the performance of RPMVCDA, five-fold cross-validation and case studies on the CircR2Disease dataset are performed, results of which shows that RPMVCDA outperforms the compared models, implying that it might be an alternative for predicting circRNA-disease associations.

4 June 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
DGDaohui Ge
Daohui Ge
XSXueyan Song
Xueyan Song
GZGuangshun Zhang
Guangshun Zhang
JYJiaying Yan
Jiaying Yan
JLJiahao Li
Jiahao Li
JLJin-xing Liu
Jin-xing Liu
Drug–drug interactions (DDIs) refer to the change in efficacy when two or more drugs taken at the same time. Reasonable DDI can enhance efficacy or reduce adverse drug reactions; otherwise, it may lead to adverse events. The recent DDI prediction methods, which use different graph neural networks to extract the drug substructures, convert the DDI prediction into the prediction of the relationship between the two drug substructures, and achieve good performance. However, these methods do not pay attention to the relationship between drug substructures extracted from the same drug. Therefore, we propose MSHGCL to constrain the relationship between drug substructures by multi-scale hierarchical graph contrastive learning module. Specifically, the intra-layer contrastive learning module constrains the relationship between drug substructures of the same scale, and the inter-layer contrastive learning module further constrains the relationship between drug substructures of adjacent layers. We evaluate MSHGCL on two real-world datasets. Experimental results show that the proposed MSHGCL method outperforms the most advanced DDI prediction method. The source code is avaliable at https://github.com/N-drinking/MSHGCL.git.